Summary All-trans retinoic acid (RA) was previously shown to regulate the growth of gastric cancer cells derived from the cell line SC-Mi. This study was designed to investigate the effect of RA on the sensitivity of SC-Mi cells to lymphokine-activated killer (LAK) activity. RA at the concentration range of 0.001-10 kM was shown to induce SC-Mi cells to exhibit resistance to LAK activity in a dose-dependent manner. A kinetics study indicated that a significantly increased resistance was detected after 2 days of co-culturing SC-Mi cells with RA and reached a maximum after 6 days of culture. Similar results were obtained from two other cancer cell lines: promyelocytic leukaemia HL-60 and hepatic cancer Hep 3B. A binding assay demonstrated that the binding efficacy between target SC-M1 cells and effector LAK cells was not altered by RA. Flow cytometric analyses revealed that RA exhibited no effect on the expression of cell surface molecules, including HLA class and class 11 antigens, intercellular adhesion molecule-1 and -2, and lymphocyte function antigen-3. Cell cycle analysis revealed that culture of SC-Mi cells with RA resulted in an increase in GJG, phase and a decrease in S phase, accompanied by a decrease in cyclin A and cyclin Bi mRNA as determined by Northern blot analysis. Additionally, RA was shown to enhance the expression of retinoic acid receptor a (RARa) in SC-Mi cells, and to have no effect on the expression of RARfi or RARy. Taken together, these results indicate that RA can significantly increase gastric cancer cells SC-Mi to resist LAK cytotoxicity by means of a cytostatic effect through a mechanism relating to cell cycle regulation. The prevailing ideas, such as a decrease in effector to target cell binding, a reduced MHC class antigen expression or an altered RARP expression, are not involved.